Antimicrobial Agents and Chemotherapy
- A pairwise approach to revitalize β-lactams for the treatment of TB
- The Spx stress regulator confers high-level β-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus
- Insights into the activity of cefiderocol against PER-2 producing Enterobacterales
- Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis
- Doxycycline, levofloxacin, and moxifloxacin are superior to ciprofloxacin in treating anthrax meningitis in rabbits and NHP
- The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase
- Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis
- Development of rabbit models of ventilator-associated bacterial pneumonia produced by carbapenem-resistant Pseudomonas aeruginosa
- In vitro activity of gepotidacin and comparator antimicrobials against isolates of nontuberculous mycobacteria (NTM)
- How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children
- Loureirin A is a narrow-spectrum antimicrobial agent against Helicobacter pylori
- Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response
- Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects
- Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs
- Ensuring a sustained workforce to combat antibiotic resistance in the 21st century: the critical need for training the next-gen of scientists at the pre-doctoral level
- Inactivation of the ribosome assembly factor RimP causes streptomycin resistance and impairs motility in Salmonellaby Zhihui LyuYunyi LingAmbro van HoofJiqiang Ling1Department of Cell Biology and Molecular Genetics, The University of Maryland, College Park, Maryland, USA2Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA on April 17, 2024 at 7:00 am
- Possibility of hypoalbuminemia itself as a risk for clinical failure
- Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis
- Genomic characterization of ST38 NDM-5-producing Escherichia coli isolates from an outbreak in the Czech Republic
- Correction for Chen et al., “Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination”by Tianyu ChenJing YaoKeao QuanJingchen XuXudong HangQian TongGenyan LiuPeipei LuoLiping ZengGanzhu FengHongkai Bi on April 16, 2024 at 7:00 am